View in EDS

Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.

Saved in:
Bibliographic Details
Title: Discovery of Diphenylacetamides as CXCR7 Inhibitors with Novel β-Arrestin Antagonist Activity.
Authors: Menhaji-Klotz E; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Ward J; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Brown JA; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Loria PM; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Tan C; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Hesp KD; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Riccardi KA; Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States., Litchfield J; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States., Boehm M; Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 May 14; Vol. 11 (6), pp. 1330-1334. Date of Electronic Publication: 2020 May 14 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1948-5875
DOI:10.1021/acsmedchemlett.0c00163